These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 32558674

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Therapeutic Drug Monitoring of Clobazam and Its Metabolite-Impact of Age and Comedication on Pharmacokinetic Variability.
    Burns ML, Baftiu A, Opdal MS, Johannessen SI, Landmark CJ.
    Ther Drug Monit; 2016 Jun; 38(3):350-7. PubMed ID: 26751267
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetic variability of everolimus and impact of concomitant antiseizure medications in patients with tuberous sclerosis complex: A retrospective study of therapeutic drug monitoring data in Denmark and Norway.
    Kirkeby K, Cockerell I, Christensen J, Hoei-Hansen CE, Holst L, Fredriksen MG, Lund C, Johannessen Landmark C.
    Medicine (Baltimore); 2024 Aug 09; 103(32):e39244. PubMed ID: 39121325
    [Abstract] [Full Text] [Related]

  • 6. Impact of Drug Interactions on Clobazam and N-Desmethylclobazam Concentrations in Pediatric Patients With Epilepsy.
    Russell GR, Phelps SJ, Shelton CM, Wheless JW.
    Ther Drug Monit; 2018 Aug 09; 40(4):452-462. PubMed ID: 29746397
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacokinetic Variability of Rufinamide and Stiripentol in Children With Refractory Epilepsy: A Retrospective Study of Therapeutic Drug Monitoring From the National Epilepsy Centers in Denmark and Norway.
    Heger K, Burns ML, Nikanorova M, Johannessen SI, Johannessen Landmark C.
    Ther Drug Monit; 2024 Oct 01; 46(5):664-671. PubMed ID: 38758628
    [Abstract] [Full Text] [Related]

  • 9. Drug-drug interactions and pharmacodynamics of concomitant clobazam and cannabidiol or stiripentol in refractory seizures.
    Klein P, Tolbert D, Gidal BE.
    Epilepsy Behav; 2019 Oct 01; 99():106459. PubMed ID: 31519475
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetic Variability of Sulthiame: The Impact of Age, Drug-Drug Interactions, and Biochemical Markers of Toxicity in Patients with Epilepsy.
    Heger K, Kjeldstadli K, Ring N, Aaberg KM, Kjeldsen SF, Burns ML, Johannessen SI, Johannessen Landmark C.
    Ther Drug Monit; 2024 Apr 01; 46(2):237-245. PubMed ID: 38158595
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Add-on stiripentol elevates serum valproate levels in patients with or without concomitant topiramate therapy.
    Jogamoto T, Yamamoto Y, Fukuda M, Suzuki Y, Imai K, Takahashi Y, Inoue Y, Ohtsuka Y.
    Epilepsy Res; 2017 Feb 01; 130():7-12. PubMed ID: 28081475
    [Abstract] [Full Text] [Related]

  • 14. Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome.
    Devinsky O, Patel AD, Thiele EA, Wong MH, Appleton R, Harden CL, Greenwood S, Morrison G, Sommerville K, GWPCARE1 Part A Study Group.
    Neurology; 2018 Apr 03; 90(14):e1204-e1211. PubMed ID: 29540584
    [Abstract] [Full Text] [Related]

  • 15. Stiripentol in Dravet syndrome: results of a retrospective U.S. study.
    Wirrell EC, Laux L, Franz DN, Sullivan J, Saneto RP, Morse RP, Devinsky O, Chugani H, Hernandez A, Hamiwka L, Mikati MA, Valencia I, Le Guern ME, Chancharme L, de Menezes MS.
    Epilepsia; 2013 Sep 03; 54(9):1595-604. PubMed ID: 23848835
    [Abstract] [Full Text] [Related]

  • 16. Long-term safety and efficacy of stiripentol for the treatment of Dravet syndrome: A multicenter, open-label study in Japan.
    Inoue Y, Ohtsuka Y, STP-1 Study Group.
    Epilepsy Res; 2015 Jul 03; 113():90-7. PubMed ID: 25986195
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pharmacokinetic variability of valproate during pregnancy - Implications for the use of therapeutic drug monitoring.
    Johannessen Landmark C, Farmen AH, Burns ML, Baftiu A, Lossius MI, Johannessen SI, Tomson T.
    Epilepsy Res; 2018 Mar 03; 141():31-37. PubMed ID: 29453075
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.